- Home
- SVRA vs HEPS Comparison
SVRA vs HEPS Comparison
Compare SVRA & HEPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SVRA | HEPS |
|---|---|---|
| Founded | 2007 | 2000 |
| Country | United States | Turkey |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2009 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SVRA | HEPS |
|---|---|---|
| Price | $4.90 | $2.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $11.06 | $3.27 |
| AVG Volume (30 Days) | ★ 2.7M | 121.2K |
| Earning Date | 11-24-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $34.24 |
| Revenue Next Year | $9,266.31 | $29.65 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.13 | $2.15 |
| 52 Week High | $7.01 | $3.30 |
Technical Indicators
Market Signals| Indicator | SVRA | HEPS |
|---|---|---|
| Relative Strength Index (RSI) | 49.75 | 54.88 |
| Support Level | $4.73 | $2.74 |
| Resistance Level | $5.47 | $2.80 |
| Average True Range (ATR) | 0.32 | 0.08 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 61.07 | 68.97 |
Price Performance
Historical ComparisonAbout SVRA Savara Inc.
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
About HEPS D-Market Electronic Services & Trading
D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. It's portfolio offers its retail customers a wide selection of merchandise including electronics and non-electronics (including books, sports, toys, kids and baby products, cosmetics, furniture, etc). The Group derives revenue from the sales of goods, marketplace revenues and other revenues.